Doubling down on efficacy: Exploring the potential of dual-payload ADCs
Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges faced by conventional ADCs. So, how did we get here, and what does the future hold for this emerging class of medicine?
